Serum and aqueous humor concentrations of interleukin-27 in diabetic retinopathy patients
- 24 July 2017
- journal article
- research article
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (5) , 1817-1823
Abstract
Purpose Interleukin (IL)-27 has been reported to possess anti- and proinflammatory properties in several immune related-disorders, but its role in diabetic retinopathy is still elusive. Here, we aimed...Keywords
This publication has 28 references indexed in Scilit:
- Interleukin-27: Balancing Protective and Pathological ImmunityImmunity, 2012
- Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1Immunity, 2012
- IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patientsGraefe's Archive for Clinical and Experimental Ophthalmology, 2012
- Interleukin-27-Mediated Suppression of Human Th17 Cells Is Associated with Activation of STAT1 and Suppressor of Cytokine Signaling Protein 1Journal of Interferon & Cytokine Research, 2011
- Diabetic retinopathyThe Lancet, 2010
- A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cellsNature Immunology, 2007
- IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T CellsImmunity, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitusDiabetologia, 1998
- Hemoglobin Components in Patients with Diabetes MellitusNew England Journal of Medicine, 1971